Background illustration for clinical trials search

Paid Clinical Trials Jackson

Discover 200 paid clinical trials in Jackson, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

for
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Location: Jackson MS, New Orleans LA, Birmingham AL, Nashville TN,
Sponsor: Duke University

Sex: All

Age: 21+

Code: NCT01915511

Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Jackson MS, New Orleans LA, Memphis TN, Little Rock AR,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase 3, Recruiting
Active & Responsive

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

for
Pressure Ulcer, Stage IV, Osteomyelitis
Location: Jackson MS, Columbia MO, Chicago IL, Omaha NE,
Sponsor: Biocomposites Ltd

Sex: All

Age: 18+

Code: NCT06283979

Phase 2, Recruiting
Active & Responsive

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)

for
ADHD
Location: Jackson MS, Memphis TN, Little Rock AR, Dothan AL,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 12 - 17

Code: NCT07717892

Phase 3, Recruiting
Active & Responsive

Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)

for
ADHD
Location: Jackson MS, Memphis TN, Little Rock AR, Dothan AL,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 6 - 11

Code: NCT07717879

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Jackson MS, Monroe LA, West Monroe LA, Covington LA,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting
Active & Responsive

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

for
Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Location: Jackson MS, Covington LA, Tupelo MS, Mobile AL,
Sponsor: Amgen

Sex: All

Age: 45 - 70+

Code: NCT07037433

Phase 3, Recruiting
Active & Responsive

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

for
Hypertension
Location: Jackson MS, Gulfport MS, New Orleans LA, Houma LA,
Sponsor: SoniVie Inc.

Sex: All

Age: 22 - 70+

Code: NCT06559891

Recruiting
Active & Responsive

Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt

for
Right-To-Left Shunt
Location: Jackson MS, Chicago IL, Milwaukee WI, Rochester MN,
Sponsor: Agitated Solutions, Inc.

Sex: All

Age: 18+

Code: NCT06938347

Phase 3, Recruiting
Active & Responsive

Encore PFO Closure Device - The PerFOrm Trial

for
Patent Foramen Ovale, Cryptogenic Stroke
Location: Jackson MS, Little Rock AR, Kansas City KS, Tampa FL,
Sponsor: Encore Medical Inc.

Sex: All

Age: 18 - 60

Code: NCT05537753

Recruiting
Active & Responsive

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

for
Ulcerative Colitis
Location: Flowood MS, Cordova TN, Tyler TX, Webster TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07186101

Phase 2, Recruiting
Active & Responsive

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Location: Flowood MS, Bastrop LA, West Monroe LA, Tuscaloosa AL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07165028

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Flowood MS, Bastrop LA, West Monroe LA, Covington LA,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Flowood MS, Bastrop LA, West Monroe LA, Covington LA,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

for
Alzheimer Disease
Location: Flowood MS, Nashville TN, Atlanta GA, DeSoto TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT06585787

Phase 3, Recruiting
Active & Responsive

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

for
Bipolar Disorder Type I With Mania
Location: Flowood MS, Little Rock AR, Atlanta GA, Houston TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT06929273

Phase 3, Recruiting
Active & Responsive

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

for
Treatment Resistant Depression
Location: Flowood MS, Birmingham AL, Huntsville AL, Brentwood TN,
Sponsor: LivaNova

Sex: All

Age: 18+

Code: NCT03887715

Recruiting
Active & Responsive

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

for
Major Depressive Disorder (MDD),
Location: Flowood MS, The Woodlands TX, Houston TX, Katy TX,
Sponsor: ACADIA Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07284667

Phase 2, Recruiting
Active & Responsive

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

for
Sickle Cell Disease
Location: Flowood MS, Birmingham AL, Riverdale GA, Houston TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06439082

Phase 3, Recruiting
Active & Responsive

A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

for
Sickle Cell Disease
Location: Flowood MS, Indianapolis IN, Grand Rapids MI
Sponsor: Agios Pharmaceuticals, Inc.

Sex: All

Age: 12+

Code: NCT07656415

Phase 3, Recruiting